← Back to headlines
Exozymes CEO Michael Heltzen buys $6,405 in company stock
Exozymes CEO Michael Heltzen acquired roughly $6,400 in company shares, marking a recent insider purchase that may indicate leadership's positive outlook on the biotechnology company.
3 Sept, 00:45 — 3 Sept, 00:45
Sources
Showing 1 of 1 sources
